Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Sage Therapeutics, Inc. | sage-ex321_7.htm |
| EX-31.2 - EX-31.2 - Sage Therapeutics, Inc. | sage-ex312_8.htm |
| EX-31.1 - EX-31.1 - Sage Therapeutics, Inc. | sage-ex311_9.htm |
| EX-21.1 - EX-21.1 - Sage Therapeutics, Inc. | sage-ex211_10.htm |
| EX-4.2 - EX-4.2 - Sage Therapeutics, Inc. | sage-ex42_260.htm |
| 10-K - 10-K - Sage Therapeutics, Inc. | sage-10k_20191231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (File No. 333-228879) and on Forms S-8 (File Nos. 333-197498, 333-204549, 333-209831, 333-216202, 333-223146, 333-228246 and 333-229732) of Sage Therapeutics, Inc. of our report dated February 27, 2020 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 27, 2020